Watermark
  Back to Search Results

BGB-A317-3111-10188-101

Completed

Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-3111-10188-101

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04282018

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20220463

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan